Skip to main content
Katherine Kerr on Muck Rack

Katherine Kerr

As seen in: WorldAtlas, Mondaq

Get in touch with Katherine

Contact Katherine, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

UPC Court Of Appeal Outlines Criteria For Jurisdiction Between UPC Courts And Links Enabling Multiple Defendants To Be Sued In One Court Including Those Not Domiciled In The UPC

|
By Rachel Montagnon, Katherine Kerr
| Mondaq
KL Herbert Smith Freehills Kramer LLP More Herbert Smith Freehills Kramer is a world-leading global law firm, where our ambition is to help you achieve your goals. Exceptional client service and the pursuit of excellence are at our core. We invest in and care about our client relationships, which is why so many are longstanding. We enjoy breaking new ground, as we have for over 170 years. As a fully integrated transatlantic and transpacific firm, we are where you need us to be.
Open in Who Shared View Duplicates (3) Issue with article?

This Wyoming Town Has The Most Walkable Downtown

|
By Katherine Kerr
| WorldAtlas
Wyoming’s most walkable downtown is in Lander, a west-central town of about 7,500 people. Main Street is delightfully compact, fitting into just a handful of tight blocks. At one end sits the 1918 Noble Hotel, and from there the sidewalks carry you past working storefronts that still pull steady foot traffic. Grab a cinnamon roll and coffee at Sinks Coffee, then wander to a bookshop, drift into a gallery, and end the loop at the brewery—everything close enough that the day practically plans itself.
Open in Who Shared Issue with article?

Preserving The Status Quo: Boehringer Ingelheim Awarded Interim Injunction

|
By Monika Klajn, Andrew Wells, Katherine Kerr
| Mondaq
Herbert Smith Freehills Kramer LLP are most popular: within Intellectual Property, Transport and Environment topic(s) in United States The Patents Court has granted Boehringer Ingelheim (BI) an interim injunction restraining Dr Reddy's Laboratories (Dr Reddy's) from launching its generic version of drug empagliflozin in the UK pending trial in October 2026.
Open in Who Shared View Duplicates (2) Issue with article?
See all 14 articles